BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15949290)

  • 1. [Clinical features and prognostic factors in primary myelofibrosis patients under 45 years old].
    Lu L; Xiao ZJ; Chen HS; Lin H; Han ZC
    Zhonghua Xue Ye Xue Za Zhi; 2005 May; 26(5):281-4. PubMed ID: 15949290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocytosis is an adverse prognostic factor for survival in younger patients with primary myelofibrosis.
    Elliott MA; Verstovsek S; Dingli D; Schwager SM; Mesa RA; Li CY; Tefferi A
    Leuk Res; 2007 Nov; 31(11):1503-9. PubMed ID: 17397921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation and comparison of contemporary prognostic models in primary myelofibrosis: analysis based on 334 patients from a single institution.
    Tefferi A; Huang J; Schwager S; Li CY; Wu W; Pardanani A; Mesa RA
    Cancer; 2007 May; 109(10):2083-8. PubMed ID: 17407134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved survival in red blood cell transfusion dependent patients with primary myelofibrosis (PMF) receiving iron chelation therapy.
    Leitch HA; Chase JM; Goodman TA; Ezzat H; Rollins MD; Wong DH; Badawi M; Leger CS; Ramadan KM; Barnett MJ; Foltz LM; Vickars LM
    Hematol Oncol; 2010 Mar; 28(1):40-8. PubMed ID: 19557769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis in transplant-eligible patients with agnogenic myeloid metaplasia: a simple CBC-based scoring system.
    Dingli D; Schwager SM; Mesa RA; Li CY; Tefferi A
    Cancer; 2006 Feb; 106(3):623-30. PubMed ID: 16369987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age and platelet count are IPSS-independent prognostic factors in young patients with primary myelofibrosis and complement IPSS in predicting very long or very short survival.
    Patnaik MM; Caramazza D; Gangat N; Hanson CA; Pardanani A; Tefferi A
    Eur J Haematol; 2010 Feb; 84(2):105-8. PubMed ID: 19895568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The risk factors for thrombosis, myelofibrosis and leukemia transformation in patients with polycythemia vera].
    Bai J; Xue YP; Ye L; Yao JF; Zhou CL; Qian LS; Yang RC; Li HY; Zhang HY; Shao ZH
    Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):685-8. PubMed ID: 18399175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic idiopathic myelofibrosis: prognostic impact of myelofibrosis and clinical parameters on event-free survival in 122 patients who presented in prefibrotic and fibrotic stages. A retrospective study identifying subgroups of different prognoses by using the RECPAM method.
    Kreft A; Weiss M; Wiese B; Choritz H; Buhr T; Büsche G; Georgii A
    Ann Hematol; 2003 Oct; 82(10):605-11. PubMed ID: 14564478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Karyotype complements the International Prognostic Scoring System for primary myelofibrosis.
    Hussein K; Huang J; Lasho T; Pardanani A; Mesa RA; Williamson CM; Ketterling RP; Hanson CA; Van Dyke DL; Tefferi A
    Eur J Haematol; 2009 Apr; 82(4):255-9. PubMed ID: 19215287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemia.
    Ghobrial IM; Fonseca R; Gertz MA; Plevak MF; Larson DR; Therneau TM; Wolf RC; Hoffmann RJ; Lust JA; Witzig TE; Lacy MQ; Dispenzieri A; Vincent Rajkumar S; Zeldenrust SR; Greipp PR; Kyle RA
    Br J Haematol; 2006 Apr; 133(2):158-64. PubMed ID: 16611306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfusion-dependency at presentation and its acquisition in the first year of diagnosis are both equally detrimental for survival in primary myelofibrosis--prognostic relevance is independent of IPSS or karyotype.
    Tefferi A; Siragusa S; Hussein K; Schwager SM; Hanson CA; Pardanani A; Cervantes F; Passamonti F
    Am J Hematol; 2010 Jan; 85(1):14-7. PubMed ID: 20029953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New prognostic index to predict survival in patients with cancer of unknown primary site with unfavourable prognosis.
    Trivanović D; Petkovic M; Stimac D
    Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):43-8. PubMed ID: 18976894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical features of multiple myeloma patients with extramedullary disease: a report of 40 cases from a single center].
    Chen HF; Fu WJ; Wang DX; Yuan ZG; Chen YB; Hou J
    Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):655-8. PubMed ID: 18399168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analyses on clinical characteristic and prognoses of 41 patients with chronic myelomonocytic leukemia in China.
    Chen B; Ma Y; Xu X; Wang X; Qin W; Ji M; Lin G
    Leuk Res; 2010 Apr; 34(4):458-62. PubMed ID: 19631982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of patients with acute myelogenous leukemia after second salvage therapy.
    Giles F; O'Brien S; Cortes J; Verstovsek S; Bueso-Ramos C; Shan J; Pierce S; Garcia-Manero G; Keating M; Kantarjian H
    Cancer; 2005 Aug; 104(3):547-54. PubMed ID: 15973664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors of metastatic renal cell carcinoma after failure of immunotherapy: new paradigm from a large phase III trial with shark cartilage extract AE 941.
    Escudier B; Choueiri TK; Oudard S; Szczylik C; Négrier S; Ravaud A; Chevreau C; Venner P; Champagne P; Croteau D; Dupont E; Hariton C; Bukowski RM
    J Urol; 2007 Nov; 178(5):1901-5. PubMed ID: 17868728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in cystic fibrosis in a single center in Brazil: A survival analysis.
    Oliveira MC; Reis FJ; Oliveira EA; Colosimo EA; Monteiro AP; Penna FJ
    Pediatr Pulmonol; 2002 Jul; 34(1):3-10. PubMed ID: 12112790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
    Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST
    Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multivariate analysis of prognostic factors in colorectal cancer patients with different ages].
    Cai SR; Zheng S; Zhang SZ
    Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):483-5. PubMed ID: 16188146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.